US 12268695
Betulin-containing birch bark extracts and their formulation
granted A61KA61K2236/00A61K31/045
Quick answer
US patent 12268695 (Betulin-containing birch bark extracts and their formulation) held by Amryt Pharmaceuticals Designated Activity Company expires Mon Apr 03 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Amryt Pharmaceuticals Designated Activity Company
- Grant date
- Tue Apr 08 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 03 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 30
- CPC classes
- A61K, A61K2236/00, A61K31/045, A61K31/56, A61K36/185